New Key Statistics Module, Z-Score and F-Score
XCNQ:BNXT Key Ratios
Market Cap C$ M | 28.25 |
Enterprise Value C$ M | 33.31 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 60.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.06 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -21.30 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -6.15 |
EV-to-EBITDA | -6.32 |
PEG | -- |
Shares Outstanding M | 113.02 |
Net Margin (%) | -20,696.77 |
Operating Margin % | -16,612.90 |
Pre-tax Margin (%) | -20,696.77 |
Quick Ratio | 0.09 |
Current Ratio | 0.09 |
ROA % (ttm) | -510.12 |
ROE % (ttm) | -- |
ROIC % (ttm) | -99.28 |
Dividend Yield % | -- |
Altman Z-Score | -102.66 |
XCNQ:BNXT Number of Guru Trades
XCNQ:BNXT Volume of Guru Trades
Gurus Latest Trades with XCNQ:BNXT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XCNQ:BNXT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BioNxt Solutions Inc Insider Transactions
No Available Data